Table 2 In-hospital procedures and treatment strategy by age category and stratified by type of AMI (n = 3475)
| Â | Age category | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Variable | 25–64 years n = 1329 (38.2) | 65–74 years n = 1083 (31.2) | 75–84 years n = 1063 (30.6) | p Value | ||||||
Type of AMI | STEMI n = 625 (47.0) | NSTEMI n = 651 (49.0) | BBB n = 53 (4.0) | STEMI n = 369 (34.1) | NSTEMI n = 603 (55.7) | BBB n = 111 (10.2) | STEMI n = 298 (28.0) | NSTEMI n = 599 (56.4) | BBB n = 166 (15.6) | <0.0001 |
Diagnostic procedure | ||||||||||
 Coronary angiography | 622 (99.5) | 606 (93.1) | 48 (90.6) | 361 (97.8) | 534 (88.6) | 94 (84.7) | 272 (91.3) | 443 (74.0) | 119 (71.7) | 0.003 |
Treatment strategy | Â | Â | Â | Â | Â | Â | Â | Â | Â | <0.0001 |
 PCI | 554 (88.6) | 460 (70.7) | 31 (58.4) | 295 (79.9) | 346 (57.4) | 69 (62.2) | 215 (72.2) | 272 (45.4) | 72 (43.4) |  |
 CABG | 49 (7.8) | 84 (12.9) | 9 (17.0) | 46 (12.5) | 118 (19.6) | 17 (15.3) | 33 (11.1) | 76 (12.7) | 15 (9.0) |  |
 No invasive therapya | 21 (3.4) | 106 (16.3) | 13 (24.5) | 28 (7.6) | 138 (22.9) | 24 (21.6) | 49 (16.4) | 251 (41.9) | 79 (47.6) |  |
 Thrombolysis | 1 (0.2) | 1 (0.2) | 0 | 0 | 1 (0.2) | 1 (0.9) | 1 (0.3) | 0 | 0 |  |
Evidence-based medication | ||||||||||
 Antiplatelet agents | 623 (99.7) | 643 (98.8) | 52 (98.1) | 367 (99.5) | 600 (99.5) | 109 (98.2) | 295 (99.0) | 590 (98.5) | 164 (98.8) | 0.24 |
 DAPT | 587 (93.9) | 543 (83.4) | 44 (83.0) | 329 (89.2) | 459 (76.1) | 82 (73.9) | 253 (84.9) | 404 (67.5) | 117 (70.5) | <0.0001 |
 Beta-blockers | 601 (96.2) | 635 (97.5) | 50 (94.3) | 351 (95.1) | 581 (96.4) | 105 (94.6) | 274 (92.0) | 565 (94.3) | 155 (93.4) | 0.0006 |
 Statins | 596 (95.4) | 612 (94.0) | 48 (90.6) | 346 (93.8) | 562 (93.2) | 94 (84.7) | 270 (90.6) | 521 (87.0) | 147 (88.6) | <0.0001 |
 ACEIs/ARBs | 587 (93.9) | 584 (89.7) | 48 (90.6) | 337 (91.3) | 544 (90.2) | 96 (86.5) | 255 (85.6) | 507 (84.6) | 139 (83.7) | <0.0001 |